サマリー

世界のB型肝炎治療薬市場 2022-2026
Technavioはb型肝炎治療薬市場を監視しており、2022-2026年の間に471.49百万ドル、予測期間中に3.29%のCAGRで進行し、成長することが予測されるとしています。b型肝炎治療薬市場に関する当レポートでは、全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、乳幼児におけるB型肝炎の有病率の増加、B型肝炎に関する認知度を高めるための取り組みの増加、HBVの分子診断に対する需要の増加によって牽引されています。
b型肝炎治療薬市場の分析には、アプリケーションセグメントと地理的展望が含まれます。
Technavioのb型肝炎治療薬市場は、以下のようにセグメント化されています。
アプリケーション別
- 医薬品
- ワクチン
地理的状況別
- 北アメリカ
- 欧州
- APAC
- その他の地域 (ROW)
本調査では、新しい技術の進歩が今後数年間のb型肝炎治療薬市場の成長を促進する主要な理由の1つであると特定しています。また、強力なパイプライン、HBV診断検査に対する認識とスクリーニングプログラムの増加が、市場の大きな需要につながると考えられます。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。b型肝炎治療薬市場に関する当レポートは、以下の分野を対象としています。
- b型肝炎治療薬市場のサイジング
- b型肝炎治療薬市場の予測
- b型肝炎治療薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、ABIVAX、Biotest AG、Bristol Myers Squibb Co.、CASI Pharmaceuticals Inc、Cipla Ltd、Dynavax Technologies Corp、F. Hoffmann La Roche Ltd.、Gilead Sciences Inc、GlaxoSmithKline Plc、Hetero Healthcare Ltd., Johnson and Johnson, Merck and Co., Inc.などを含むいくつかの主要b型肝炎治療薬のベンダーについての詳細分析を提供しています。Inc.、Novartis AG、Sanofi SA、Teva Pharmaceutical Industries Ltd.、Viatris Inc.、Emergent BioSolutions Inc.の各社が含まれています。また、b型肝炎治療薬市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略化し、活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/hepatitis-b-therapeutics-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Application
o 5.1 Market segments
o Exhibit 24: Chart on Application - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
o 5.2 Comparison by Application
o Exhibit 26: Chart on Comparison by Application
o Exhibit 27: Data Table on Comparison by Application
o 5.3 Drugs - Market size and forecast 2021-2026
o Exhibit 28: Chart on Drugs - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Drugs - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Drugs - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Drugs - Year-over-year growth 2021-2026 (%)
o 5.4 Vaccines - Market size and forecast 2021-2026
o Exhibit 32: Chart on Vaccines - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Vaccines - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Vaccines - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Vaccines - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Application
o Exhibit 36: Market opportunity by Application ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 APAC - Market size and forecast 2021-2026
o Exhibit 50: Chart on APAC - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on APAC - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on APAC - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 Canada - Market size and forecast 2021-2026
o Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.10 Brazil - Market size and forecast 2021-2026
o Exhibit 70: Chart on Brazil - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Brazil - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Brazil - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Brazil - Year-over-year growth 2021-2026 (%)
o 7.11 China - Market size and forecast 2021-2026
o Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Biotest AG
o Exhibit 85: Biotest AG - Overview
o Exhibit 86: Biotest AG - Business segments
o Exhibit 87: Biotest AG - Key offerings
o Exhibit 88: Biotest AG - Segment focus
o 10.4 Bristol Myers Squibb Co.
o Exhibit 89: Bristol Myers Squibb Co. - Overview
o Exhibit 90: Bristol Myers Squibb Co. - Product / Service
o Exhibit 91: Bristol Myers Squibb Co. - Key offerings
o 10.5 Dynavax Technologies Corp.
o Exhibit 92: Dynavax Technologies Corp. - Overview
o Exhibit 93: Dynavax Technologies Corp. - Product / Service
o Exhibit 94: Dynavax Technologies Corp. - Key news
o Exhibit 95: Dynavax Technologies Corp. - Key offerings
o 10.6 Emergent BioSolutions Inc.
o Exhibit 96: Emergent BioSolutions Inc. - Overview
o Exhibit 97: Emergent BioSolutions Inc. - Product / Service
o Exhibit 98: Emergent BioSolutions Inc. - Key news
o Exhibit 99: Emergent BioSolutions Inc. - Key offerings
o 10.7 F. Hoffmann La Roche Ltd.
o Exhibit 100: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 101: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 102: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 103: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 104: F. Hoffmann La Roche Ltd. - Segment focus
o 10.8 Gilead Sciences Inc.
o Exhibit 105: Gilead Sciences Inc. - Overview
o Exhibit 106: Gilead Sciences Inc. - Product / Service
o Exhibit 107: Gilead Sciences Inc. - Key news
o Exhibit 108: Gilead Sciences Inc. - Key offerings
o 10.9 GlaxoSmithKline Plc
o Exhibit 109: GlaxoSmithKline Plc - Overview
o Exhibit 110: GlaxoSmithKline Plc - Business segments
o Exhibit 111: GlaxoSmithKline Plc - Key news
o Exhibit 112: GlaxoSmithKline Plc - Key offerings
o Exhibit 113: GlaxoSmithKline Plc - Segment focus
o 10.10 Merck and Co. Inc.
o Exhibit 114: Merck and Co. Inc. - Overview
o Exhibit 115: Merck and Co. Inc. - Business segments
o Exhibit 116: Merck and Co. Inc. - Key news
o Exhibit 117: Merck and Co. Inc. - Key offerings
o Exhibit 118: Merck and Co. Inc. - Segment focus
o 10.11 Novartis AG
o Exhibit 119: Novartis AG - Overview
o Exhibit 120: Novartis AG - Business segments
o Exhibit 121: Novartis AG - Key offerings
o Exhibit 122: Novartis AG - Segment focus
o 10.12 Viatris Inc.
o Exhibit 123: Viatris Inc. - Overview
o Exhibit 124: Viatris Inc. - Business segments
o Exhibit 125: Viatris Inc. - Key offerings
o Exhibit 126: Viatris Inc. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 127: Inclusions checklist
o Exhibit 128: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 129: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 130: Research methodology
o Exhibit 131: Validation techniques employed for market sizing
o Exhibit 132: Information sources
o 11.5 List of abbreviations
o Exhibit 133: List of abbreviations

Exhibits
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Application - Market share 2021-2026 (%)
Exhibits25: Data Table on Application - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Application
Exhibits27: Data Table on Comparison by Application
Exhibits28: Chart on Drugs - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Drugs - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Drugs - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Drugs - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Vaccines - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Vaccines - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Vaccines - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Vaccines - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Application ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on APAC - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on APAC - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on APAC - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Brazil - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Brazil - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Brazil - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Brazil - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Biotest AG - Overview
Exhibits86: Biotest AG - Business segments
Exhibits87: Biotest AG - Key offerings
Exhibits88: Biotest AG - Segment focus
Exhibits89: Bristol Myers Squibb Co. - Overview
Exhibits90: Bristol Myers Squibb Co. - Product / Service
Exhibits91: Bristol Myers Squibb Co. - Key offerings
Exhibits92: Dynavax Technologies Corp. - Overview
Exhibits93: Dynavax Technologies Corp. - Product / Service
Exhibits94: Dynavax Technologies Corp. - Key news
Exhibits95: Dynavax Technologies Corp. - Key offerings
Exhibits96: Emergent BioSolutions Inc. - Overview
Exhibits97: Emergent BioSolutions Inc. - Product / Service
Exhibits98: Emergent BioSolutions Inc. - Key news
Exhibits99: Emergent BioSolutions Inc. - Key offerings
Exhibits100: F. Hoffmann La Roche Ltd. - Overview
Exhibits101: F. Hoffmann La Roche Ltd. - Business segments
Exhibits102: F. Hoffmann La Roche Ltd. - Key news
Exhibits103: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits104: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits105: Gilead Sciences Inc. - Overview
Exhibits106: Gilead Sciences Inc. - Product / Service
Exhibits107: Gilead Sciences Inc. - Key news
Exhibits108: Gilead Sciences Inc. - Key offerings
Exhibits109: GlaxoSmithKline Plc - Overview
Exhibits110: GlaxoSmithKline Plc - Business segments
Exhibits111: GlaxoSmithKline Plc - Key news
Exhibits112: GlaxoSmithKline Plc - Key offerings
Exhibits113: GlaxoSmithKline Plc - Segment focus
Exhibits114: Merck and Co. Inc. - Overview
Exhibits115: Merck and Co. Inc. - Business segments
Exhibits116: Merck and Co. Inc. - Key news
Exhibits117: Merck and Co. Inc. - Key offerings
Exhibits118: Merck and Co. Inc. - Segment focus
Exhibits119: Novartis AG - Overview
Exhibits120: Novartis AG - Business segments
Exhibits121: Novartis AG - Key offerings
Exhibits122: Novartis AG - Segment focus
Exhibits123: Viatris Inc. - Overview
Exhibits124: Viatris Inc. - Business segments
Exhibits125: Viatris Inc. - Key offerings
Exhibits126: Viatris Inc. - Segment focus
Exhibits127: Inclusions checklist
Exhibits128: Exclusions checklist
Exhibits129: Currency conversion rates for US$
Exhibits130: Research methodology
Exhibits131: Validation techniques employed for market sizing
Exhibits132: Information sources
Exhibits133: List of abbreviations